peroxynitrous acid has been researched along with aspirin in 9 studies
| Studies (peroxynitrous acid) | Trials (peroxynitrous acid) | Recent Studies (post-2010) (peroxynitrous acid) | Studies (aspirin) | Trials (aspirin) | Recent Studies (post-2010) (aspirin) |
|---|---|---|---|---|---|
| 3,303 | 21 | 1,230 | 48,947 | 6,817 | 13,778 |
| Protein | Taxonomy | peroxynitrous acid (IC50) | aspirin (IC50) |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | Bos taurus (cattle) | 0.35 | |
| Integrin beta-3 | Homo sapiens (human) | 5 | |
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 0.8252 | |
| Seed linoleate 13S-lipoxygenase-1 | Glycine max (soybean) | 1.375 | |
| Integrin alpha-IIb | Homo sapiens (human) | 5 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 2.271 | |
| Substance-P receptor | Cavia porcellus (domestic guinea pig) | 2.4 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 2.15 | |
| Urotensin-2 receptor | Rattus norvegicus (Norway rat) | 0.3 | |
| 4-aminobutyrate aminotransferase, mitochondrial | Rattus norvegicus (Norway rat) | 2.4 | |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.35 | |
| Prostaglandin G/H synthase 2 | Ovis aries (sheep) | 2.4081 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Bradley, NJ; Bruckdorfer, KR; Jacobs, M; Khan, J; Low, SY; Naseem, KM; Sabetkar, M | 1 |
| Filep, JG; József, L; Petasis, NA; Serhan, CN; Zouki, C | 1 |
| Korda, M; Madajka, M; Malinski, T; White, J | 1 |
| Whittle, BJ | 1 |
| Colantuono, G; Khan, M; Kumbala, D; Kuppusamy, P; Kutala, VK; Mandal, R; Potaraju, V | 1 |
| Chen, W; Jia, Z; Li, J; Li, Y; Misra, HP; Zhou, K; Zhu, H | 1 |
| Davì, G; La Barba, S; Lapenna, D; Santilli, F | 1 |
| Bauer, G | 1 |
| Bortner, CD; Sinha, BK; Tokar, EJ | 1 |
2 review(s) available for peroxynitrous acid and aspirin
| Article | Year |
|---|---|
Nitric oxide-modulating agents for gastrointestinal disorders.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Enteritis; Esophagus; Fissure in Ano; Gastric Emptying; Gastrointestinal Diseases; Gastrointestinal Motility; Humans; Naproxen; Nitrates; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type II; Peroxynitrous Acid | 2005 |
Oxidative stress-related mechanisms affecting response to aspirin in diabetes mellitus.
Topics: Aldehyde Reductase; Aspirin; Blood Platelets; Diabetes Mellitus, Type 2; F2-Isoprostanes; Glucose; Glycosylation; Humans; Lipid Peroxides; Nitric Oxide; Oxidative Stress; Peroxynitrous Acid; Platelet Activation; Platelet Aggregation Inhibitors; Thrombosis; Thromboxane A2 | 2015 |
7 other study(ies) available for peroxynitrous acid and aspirin
| Article | Year |
|---|---|
The nitration of platelet cytosolic proteins during agonist-induced activation of platelets.
Topics: Aspirin; Blood Platelets; Blood Proteins; Blotting, Western; Cell Adhesion Molecules; Collagen; Cyclooxygenase Inhibitors; Cytosol; Enzyme-Linked Immunosorbent Assay; Humans; Membrane Proteins; Microfilament Proteins; Molecular Weight; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide Synthase; Nitrous Acid; Oxidants; Peroxynitrous Acid; Phosphoproteins; Platelet Activation; Thrombin; Tyrosine | 2000 |
Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Cell Nucleus; Cell Survival; Dose-Response Relationship, Drug; Humans; Hydroxyeicosatetraenoic Acids; Interleukin-8; Leukocytes; Lipoxins; Lymphocytes; Neutrophils; NF-kappa B; Peroxynitrous Acid; Ribonucleases; Superoxides; Transcription Factor AP-1 | 2002 |
Effect of aspirin on constitutive nitric oxide synthase and the biovailability of NO.
Topics: Animals; Arginine; Aspirin; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Humans; Nitric Oxide; Nitric Oxide Synthase; PC12 Cells; Peroxynitrous Acid; Rats; Superoxides; Umbilical Veins | 2003 |
Prevention of postischemic myocardial reperfusion injury by the combined treatment of NCX-4016 and Tempol.
Topics: Animals; Aspirin; Creatine Kinase; Cyclic N-Oxides; L-Lactate Dehydrogenase; Myocardial Ischemia; Myocardial Reperfusion Injury; Nitric Oxide; Peroxynitrous Acid; Rats; Rats, Sprague-Dawley; Spin Labels; Superoxide Dismutase; Superoxides; Uric Acid | 2006 |
Inhibition of peroxynitrite-mediated DNA strand cleavage and hydroxyl radical formation by aspirin at pharmacologically relevant concentrations: implications for cancer intervention.
Topics: Anticarcinogenic Agents; Aspirin; Bacteriophage phi X 174; DNA Cleavage; Humans; Hydroxyl Radical; Molsidomine; Neoplasms; Peroxynitrous Acid; Plasmids | 2009 |
Increasing the endogenous NO level causes catalase inactivation and reactivation of intercellular apoptosis signaling specifically in tumor cells.
Topics: Apoptosis; Aspirin; Catalase; Cell Line, Tumor; fas Receptor; Gene Expression Regulation, Neoplastic; Humans; Hydrogen Peroxide; Hypochlorous Acid; Metalloporphyrins; Neoplasms; Nitrates; Nitric Oxide; Peroxynitrous Acid; Proton Pumps; Signal Transduction; Singlet Oxygen | 2015 |
Molecular Mechanisms of Cytotoxicity of NCX4040, the Non-Steroidal Anti-Inflammatory NO-Donor, in Human Ovarian Cancer Cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Aspirin; Carcinoma, Ovarian Epithelial; Doxorubicin; Female; Humans; Nitro Compounds; Ovarian Neoplasms; Peroxynitrous Acid; Reactive Nitrogen Species; Reactive Oxygen Species | 2022 |